Brown adipose-derived mesenchymal stromal cells improve sepsis-induced multiorgan dysfunction more than white adipose cells in obese rats.
Silva JD., Lopes-Pacheco M., de Carvalho LRP., Abreu SC., da Silva MMA., Melo MM.
Animal Study on Chronic Inflammation, published in Cytotherapy (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Cytotherapy (2026)
- Country
- England
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41916150
- DOI
- 10.1016/j.jcyt.2026.102134
Abstract (original English)
Background/aims Sepsis remains a leading cause of mortality worldwide and is driven by a dysregulated host response to infection. Mesenchymal stromal cells (MSCs) derived from white adipose tissue (WAT) have shown therapeutic potential in sepsis; however, the properties of brown adipose tissue (BAT)-derived MSCs remain poorly characterized, particularly in obesity, a condition known to alter MSC phenotype and function. We compared the therapeutic efficacy of MSCs isolated from brown versus white adipose depots of obese donors in a clinically relevant model of sepsis in obese rats. Methods Obesity was induced in Wistar rats through a high-fat diet. MSCs were isolated from brown and white adipose tissue and characterized by plastic adherence, surface marker expression, and gene expression profiling. Sepsis was induced by cecal ligation and puncture (CLP). Twenty-four hours after CLP, animals received saline, WAT-MSCs, or BAT-MSCs (1 × 10⁶ cells). Primary outcomes were 48-h survival and bacterial burden. Secondary outcomes included blinded histological assessment and molecular analyses of lung, kidney, and liver injury, focusing on inflammatory cytokines, fibrotic signaling, and oxidative stress. Results Both MSC populations met established characterization criteria. BAT-MSCs exhibited higher baseline expression of anti-inflammatory and antioxidant genes. In obese septic rats, tre
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Comparing Regenerative Biologics and Standard Pharmacotherapy for Chronic Rotator Cuff Tendinopathy: A Study of PRP, Cell-Based, and Peptide Interventions
Systematic Review on Tendon Injury, Rotator Cuff, Shoulder Pain, Chronic Inflammation, published in J Orthop Sports Med (2026) — summary generated from the PubMed abstract.
- 2026
J Orthop Sports Med - Level ASystematic ReviewEurope PMC
Harnessing exosomes in dry eye disease: a triple threat approach
Systematic Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in BMC Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
BMC Ophthalmol - Level AMeta-analysisPubMed
Comparative efficacy of different doses of mesenchymal stem cells derived from different tissue sources for knee osteoarthritis: a systematic review and network meta-analysis of randomized controlled trials.
Meta-analysis with a reported sample of 602 on Knee Osteoarthritis, Osteoarthritis, Chronic Inflammation, Immune Modulation, published in PeerJ (2026) — summary generated from the PubMed abstract.
- 2026
- n = 602
PeerJ - Level ASystematic ReviewEurope PMC
Exosomes as Cellular Communicators and Therapeutic Agents in Orthopedic Diseases: From Mechanisms to Intervention
Systematic Review on Osteoarthritis, Chronic Inflammation, published in Int J Nanomedicine (2026) — summary generated from the PubMed abstract.
- 2026
Int J Nanomedicine1 citations - Level ASystematic ReviewEurope PMC
Pharmacotherapy agents in prevention and treatment of breast cancer-related lymphedema: a systematic scoping review
Systematic Review on Chronic Inflammation, Immune Modulation, published in Front Oncol (2026) — summary generated from the PubMed abstract.
- 2026
Front Oncol - Level ASystematic ReviewEurope PMC
Trends in peripheral nerve injury research: a bibliometric analysis focused on molecular mechanisms
Systematic Review on Chronic Inflammation, published in Front Neurol (2026) — summary generated from the PubMed abstract.
- 2026
Front Neurol